Lasev Pharma Consulting SRL
Lasev Pharma Consulting reported total assets of 92,844 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Apr 2026).
The score of Lasev Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lasev Pharma Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Apr 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
Lasev Pharma Consulting's financial analysis
- Solvency73.4%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lasev Pharma Consulting
Lasev Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.507.072
- VAT number
- BE1013507072
- Peppol
- Registered · 0208:1013507072 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Sep 2024
- Registered office
- 4560 Clavier
- Latest accounts
- 2025 · filed on 29 Apr 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Lasev Pharma Consulting (SRL) has been based in Clavier since 2024, active in: business and other management consultancy activities. For 2025, it reports a net profit of 53,920 € and equity of 68,160 €; its revenue is not published. Its solvency stands at 73.4%, above the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lasev Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- JNC Move Business and other management consultancy activities Wemmel · balance sheet 92,850 €
- ADL Advisory Business and other management consultancy activities Uccle · balance sheet 92,853 €
- Goodswitch Business and other management consultancy activities Hamois · balance sheet 92,855 €
- DrieB Business and other management consultancy activities Boutersem · balance sheet 92,830 €
- Step International Business and other management consultancy activities Bruges · balance sheet 92,859 €
- MaGe Business and other management consultancy activities Uccle · balance sheet 92,828 €
- PHOR Care Management Business and other management consultancy activities Rixensart · balance sheet 92,877 €
- Schleich Orthopedie Business and other management consultancy activities Péruwelz · balance sheet 92,904 €
Frequently asked questions about Lasev Pharma Consulting
What is the revenue of Lasev Pharma Consulting?
Lasev Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lasev Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE1013507072 for Lasev Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 1013.507.072.
Where is the registered office of Lasev Pharma Consulting?
According to the CBE register, the registered office of Lasev Pharma Consulting is in 4560 Clavier.
What is the equity of Lasev Pharma Consulting?
At the close of the 2025 financial year, the equity of Lasev Pharma Consulting amounts to 68,160 €, a solvency of 73.4% of total assets.
Who manages Lasev Pharma Consulting?
The register lists 1 active mandates at Lasev Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lasev Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →